Patent · US Active

Spiroindolinone derivatives

US7723372B2 · kind B2 · utility

6Cited by
2References
9Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 18, 2009
Grant dateMay 25, 2010
Priority date—
Expiry dateFeb 18, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

There are provided compounds of the general formulaswherein W, X, Y, R1, R2, R3, and R4 are as described herein. The compounds exhibit anticancer activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.